Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database

Overview of attention for article published in Cadernos de Saúde Pública, January 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 1,882)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

policy: 1 policy source

twitter: 198 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

An in vitro study for reducing the cytotoxicity and dose dumping risk of remdesivir via entrapment in nanostructured lipid carriers

Article in Scientific Reports (August 2024)

Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center

Article in Annals of Medicine (June 2024)

Remdesivir: treatment of COVID-19 in special populations

Article in Naunyn-Schmiedeberg's Archives of Pharmacology (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.